Aggrenox Judge Questions Need For Broad Market Discovery
A Connecticut federal judge ordered Boehringer Ingelheim and Teva on Friday to show why discovery in a pay-for-delay case over Aggrenox should not be limited solely to that stroke-prevention drug, saying...To view the full article, register now.
Already a subscriber? Click here to view full article